InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,187.70
(
0.13%
)
US TECH 100
17,572.00
(
-0.23%
)
Dow Jones
38,884.26
(
0.00%
)
Brent Oil
82.00
(
-1.04%
)
Bitcoin
62,373.61
(
0.06%
)
Post# of 3833
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Coolec78

Send PM Follow Ignore
Followers 1
Posts 77
Boards Moderated 0
Alias Born 11/25/2015

Coolec78

Re: biotech2010 post# 2830

Thursday, 02/09/2017 10:13:15 AM

Thursday, February 09, 2017 10:13:15 AM

Post# of 3833
Yup. Then biotech2010 explains something there is nothing to add.
I'm long OGXI shareholder. 2 years ago they had 2 drugs I multiple PHASE 3 !!!!!!!!!! trials
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent GALT News
More GALT News
InvestorsHub NewsWire

FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Start posting your company's news
Only $200 per official company press release!